Related Experiment Video
Updated: May 13, 2026
04:30
Stimulated Single Fiber Electromyography (SFEMG) for Assessing Neuromuscular Junction Transmission in Rodent Models
Published on: March 8, 2024
Neuromuscular blocking effect of fluoxetine and its interaction with rocuronium
J C Patel1, M J Barvaliya, T K Patel
1Department of Pharmacology, Government Medical College, Bhavanagar, 364001, Gujarat, India.
Autonomic & Autacoid Pharmacology
|March 7, 2013
Summary
Selective serotonin reuptake inhibitors like fluoxetine can affect neuromuscular transmission. This study found fluoxetine blocks neuromuscular signals and enhances rocuronium
Area of Science:
- Pharmacology
- Neuroscience
Background:
- Selective serotonin reuptuptake inhibitors (SSRIs) interact with nicotinic acetylcholine receptors.
- This interaction may influence neuromuscular transmission and affect neuromuscular blocking agents.
Purpose of the Study:
- To investigate the impact of fluoxetine on neuromuscular transmission.
- To examine the interaction between fluoxetine and rocuronium, a neuromuscular blocker.
Main Methods:
- Rat phrenic nerve hemidiaphragm preparations were used to assess neuromuscular transmission.
- Cumulative dose-response curves (DRCs) for fluoxetine and rocuronium were generated.
- Rabbit head drop assay was employed to evaluate in vivo effects.
Main Results:
- Fluoxetine demonstrated inhibitory effects on both indirectly and directly stimulated neuromuscular responses.
- Fluoxetine significantly increased the potency of rocuronium, decreasing its ED50 and ED95 values.
- In rabbits, fluoxetine pretreatment shortened the time to head drop after rocuronium administration.
Conclusions:
- Fluoxetine impairs neuromuscular transmission.
- Fluoxetine enhances the neuromuscular blocking effect of rocuronium.
- Clinical implications for patients on SSRIs and neuromuscular blockers warrant consideration.
Related Concept Videos
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
01:11Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
01:21Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
01:28Depolarizing Blockers: Mechanism of Action
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
01:29Neuromuscular Junction And Blockade
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...